SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: 8-K
Document Type: EX-99.1
Date Filed: 2025-08-27
Accession Number: 0001213900-25-081175
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025081175/ea025480001ex99-1_synergy.htm

Chunk 0 of 1
Word Count: 703
Character Count: 4775

Document Content:

Exhibit 99.1

Synergy CHC Corp. Announces Pricing of $4.375
Million Public Offering

WESTBROOK, Maine, Aug. 25, 2025 – Synergy
CHC Corp. (Nasdaq: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced
the pricing of an underwritten public offering of 1,750,000 shares of common stock at a public offering price of $2.50 per share for aggregate
gross proceeds of $4.375 million prior to deducting underwriting discounts and commissions, and other offering expenses. In addition,
the Company has granted the underwriters a 45-day option to purchase up to an additional 262,500 shares at the public offering price less
the underwriting discounts and commissions. The offering is expected to close on Wednesday, August 27, 2025, subject to satisfaction of
customary closing conditions.

The Company intends to use the net proceeds from
the offering for working capital and other general corporate purposes.

The Company has agreed to issue to the underwriter
warrants to purchase up to 52,500 shares of common stock (or 60,375 if the over-allotment is exercised), exercisable beginning 180 days
from the closing of the offering. The warrants will expire in tranches: twenty-five percent (25%) on the third anniversary of the closing
date of the offering, twenty-five percent (25%) on the fourth anniversary of such closing date, and the remaining fifty percent (50%)
on the fifth anniversary of such closing date.

Bancroft Capital, LLC is acting as the sole book-running
manager for the offering.

A registration statement
on Form S-1 (File No. 333-289645) relating to these securities was filed with the Securities and Exchange Commission (SEC) on August 15,
2025, and was declared effective on August 25, 2025. A final prospectus relating to the offering will be filed with the SEC and will be
available at the SEC’s website at www.sec.gov or from Bancroft Capital, LLC by email at investmentbanking@bancroft4vets.com, by
standard mail to 501 Office Center Drive, Suite 130, Fort Washington, PA 19034, or by telephone at +1 (484) 546-8000.

This press release shall not constitute an offer
to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities
in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or jurisdiction.

About Synergy CHC Corp.

Synergy CHC Corp. develops and markets consumer
health and wellness products, led by its flagship brands FOCUSfactor® and Flat Tummy®. FOCUSfactor®,
a clinically studied brain health supplement and functional beverage line with a 25-year legacy, enjoys established distribution
in the U.S., Canada, and the U.K. through major retailers including Costco, Walmart, Amazon, BJ’s, and Walgreens, among
others. The brand continues to accelerate growth, penetrating new markets both domestically and internationally, with recent retail wins
across mass, grocery, pharmacy, convenience, and wholesale channels poised to drive meaningful gains in late 2025. Flat Tummy® complements
Synergy’s portfolio as a lifestyle brand focused on women’s wellness and weight management.

Forward-Looking Statements

Certain statements in this press release that
are not historical facts are forward-looking statements that reflect management’s current expectations, assumptions, and estimates
of future performance and economic conditions, and involve risks and uncertainties that could cause actual results to differ materially
from those anticipated by the statements made herein. Forward-looking statements are generally identifiable by the use of forward-looking
terminology such as “believe,” “expects,” “may,” “looks to,” “will,” “should,”
“plan,” “intend,” “on condition,” “target,” “see,” “potential,”
“estimates,” “preliminary,” or “anticipates” or the negative thereof or comparable terminology, or
by discussion of strategy or goals or other future events, circumstances, or effects. Moreover, forward-looking statements in this release
include, but are not limited to, the expectation that the proposed offering will be successfully completed. Further information relating
to factors that may impact the Company’s results and forward-looking statements are disclosed in the Company’s filings with
the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company
disclaims any intention or obligation, other than imposed by law, to update or revise any forward-looking statements, whether as a result
of new information, future events, or otherwise.

Investor Relations

Gateway Group

Cody Slach, Greg Robles

SNYR@gateway-grp.com